Literature DB >> 33145707

Brain-derived neurotrophic factor (BDNF) is associated with depressive symptoms in older adults with HIV disease.

Steven Paul Woods1, Michelle Babicz2, Lokesh Shahani3, Gabriela Delevati Colpo3, Erin E Morgan4, Antonio L Teixeira3.   

Abstract

Symptoms of depression are common among persons with HIV (PWH) and can have a significant impact on socioeconomic and personal well-being, but little is known about their neurobiological substrates in the context of HIV disease. This study examined the possible role of brain-derived neurotrophic factor (BDNF) in symptoms of depression and other aspects of mood in 109 PWH and 43 seronegative participants aged 50 and older. Participants completed the Profile of Mood States (POMS) which measured six dimensions of mood and was normatively adjusted for sex. A model controlling for medical comorbidities and substance use diagnoses among PWH showed a significant interaction between BDNF and POMS subscales. Planned post hoc analyses revealed that lower BDNF was only associated with higher scores on Depression-Dejection and Confusion-Bewilderment POMS subscales among PWH and at small-to-medium effect sizes. Lower levels of BDNF were associated with AIDS diagnoses and CD4 count, but not with viremia or duration of infection. BDNF levels did not differ between the PWH and HIV - samples, and there were no significant correlations between BDNF and any POMS variable in the HIV - group. Findings implicate BDNF in the neuropathophysiology of specific depressive symptoms in the context of HIV disease. Future studies may examine whether BDNF levels change over time, are sensitive to other aspects of mood disorders in HIV, and are associated with markers of HIV-associated neural injury.

Entities:  

Keywords:  Biomarkers; Infectious disease; Major depressive disorder; Neuropsychiatry

Mesh:

Substances:

Year:  2020        PMID: 33145707     DOI: 10.1007/s13365-020-00916-2

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  54 in total

Review 1.  Effectiveness of psychological treatments for depressive symptoms among people living with HIV/AIDS in low- and middle-income countries: A systematic review and meta-analysis.

Authors:  Biksegn Asrat; Marguerite Schneider; Fentie Ambaw; Crick Lund
Journal:  J Affect Disord       Date:  2020-04-09       Impact factor: 4.839

2.  Assessing the influence of confounding subject variables in neuropsychological research in alcoholism and related disorders.

Authors:  A I Alterman; R E Tarter
Journal:  Int J Neurosci       Date:  1985-04       Impact factor: 2.292

3.  HIV-1 decreases the levels of neurotrophins in human lymphocytes.

Authors:  Valeriya Avdoshina; Alfredo Garzino-Demo; Alessia Bachis; Maria C G Monaco; Pauline M Maki; Rochelle E Tractenberg; Chenglong Liu; Mary A Young; Italo Mocchetti
Journal:  AIDS       Date:  2011-05-15       Impact factor: 4.177

4.  Human immunodeficiency virus type 1 alters brain-derived neurotrophic factor processing in neurons.

Authors:  Alessia Bachis; Valeriya Avdoshina; Luigi Zecca; Maia Parsadanian; Italo Mocchetti
Journal:  J Neurosci       Date:  2012-07-11       Impact factor: 6.167

5.  Single-nucleotide polymorphisms in TrkB and risk for depression: findings from the women's interagency HIV study.

Authors:  Valeriya Avdoshina; Italo Mocchetti; Chenglong Liu; Mary A Young; Kathryn Anastos; Mardge Cohen; Howard Crystal; Celeste L Pearce; Elizabeth T Golub; Rochelle E Tractenberg
Journal:  J Acquir Immune Defic Syndr       Date:  2013-10-01       Impact factor: 3.731

Review 6.  HIV infection and depression.

Authors:  Stylianos Arseniou; Aikaterini Arvaniti; Maria Samakouri
Journal:  Psychiatry Clin Neurosci       Date:  2013-10-30       Impact factor: 5.188

7.  Gender Differences in Severity and Correlates of Depression Symptoms in People Living with HIV in Ontario, Canada.

Authors:  Kinda Aljassem; Janet M Raboud; Trevor A Hart; Anita Benoit; DeSheng Su; Shari L Margolese; Sean B Rourke; Sergio Rueda; Ann Burchell; John Cairney; Paul Shuper; Mona R Loutfy
Journal:  J Int Assoc Provid AIDS Care       Date:  2014-06-04

8.  Association of depression, anxiety, and suicidal ideation with high-risk behaviors among men who inject drugs in Delhi, India.

Authors:  Gregory Armstrong; Anthony F Jorm; Luke Samson; Lynette Joubert; Amenla Nuken; Shalini Singh; Michelle Kermode
Journal:  J Acquir Immune Defic Syndr       Date:  2013-12-15       Impact factor: 3.731

Review 9.  A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression.

Authors:  André Russowsky Brunoni; Mariana Lopes; Felipe Fregni
Journal:  Int J Neuropsychopharmacol       Date:  2008-08-28       Impact factor: 5.176

Review 10.  Prevalence and Associated Factors of Depression among PLHIV in Ethiopia: Systematic Review and Meta-Analysis, 2017.

Authors:  Tadele Amare; Wondale Getinet; Shegaye Shumet; Biksegn Asrat
Journal:  AIDS Res Treat       Date:  2018-02-28
View more
  6 in total

Review 1.  Neuroinflammation in HIV-associated depression: evidence and future perspectives.

Authors:  Arish Mudra Rakshasa-Loots; Heather C Whalley; Jaime H Vera; Simon R Cox
Journal:  Mol Psychiatry       Date:  2022-05-26       Impact factor: 13.437

Review 2.  Serum and plasma levels of brain-derived neurotrophic factor in individuals with eating disorders (EDs): a systematic review and meta-analysis.

Authors:  Parnian Shobeiri; Sara Bagherieh; Parsa Mirzayi; Amirali Kalantari; Omid Mirmosayyeb; Antônio L Teixeira; Nima Rezaei
Journal:  J Eat Disord       Date:  2022-07-18

3.  Differential Associations Between BDNF and Memory Across Older Black and White Adults With HIV Disease.

Authors:  Pariya L Fazeli; Steven P Woods; Crystal C Lambert; Wei Li; Cierra N Hopkins; David E Vance
Journal:  J Acquir Immune Defic Syndr       Date:  2022-02-01       Impact factor: 3.771

Review 4.  Neurotrophin Signaling Impairment by Viral Infections in the Central Nervous System.

Authors:  Karen Bohmwald; Catalina A Andrade; Valentina P Mora; José T Muñoz; Robinson Ramírez; María F Rojas; Alexis M Kalergis
Journal:  Int J Mol Sci       Date:  2022-05-22       Impact factor: 6.208

5.  HIV on the brain: is neurosignalling damage irreversible even on antiretroviral therapy?

Authors:  C Sabrina Tan; R Keith Reeves
Journal:  AIDS       Date:  2021-07-15       Impact factor: 4.632

6.  Antiretroviral therapy administration reduces neuroinflammation without restoring brain-derived neurotrophic factor signaling in alcohol-administered simian immunodeficiency virus-infected macaques.

Authors:  John K Maxi; Brittany L Foret; Angela M Amedee; Lee S McDaniel; Steve Nelson; Liz Simon; Scott Edwards; Patricia E Molina
Journal:  AIDS       Date:  2021-07-15       Impact factor: 4.632

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.